Despite an end to the recent IV fluid shortage being in sight, hospital administrators may continue to adjust standard practices, KFF Health News reported Nov. 27. 

Clinicians and patients should avoid using compounded GLP-1 products that are not FDA-approved, the American Diabetes Association wrote in a guidance statement published Dec. 2 in Diabetes Care.

The shrinking presence of brick-and-mortar pharmacies is opening doors for new chain models to emerge, NJBiz reported Dec. 2.

The Comanche County Medical Center health system has bought a pharmacy in Goldthwaite, Texas. 

Sanofi is preparing a new vaccine and biopharmaceutical manufacturing facility in Singapore, located at Tuas Biomedical Park, Bloomberg reported Nov. 27. 

Medicare beneficiaries are facing wide price discrepancies for prescription drugs, with the same medication costing vastly different amounts, depending on the plan and location, The Wall Street Journal  reported Nov. 26. 

GLP-1 medications like Mounjaro and Saxenda might benefit stroke survivors and reduce some patients' healthcare costs, according to researchers. 

Cassava Sciences announced that the phase 3 trial of its Alzheimer's drug, simufilam, did not meet its primary endpoints. 

In a Nov. 25 letter sent to congressional leaders, the Healthcare Leadership Council pressed legislators to restore pandemic-era pharmacist scopes of practice.

A new study on asthma medication Singulair has raised concerns about its potential mental health side effects, USA Today reported Nov. 24.